Goldman Sachs’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.52M Sell
134,398
-205,538
-60% -$2.32M ﹤0.01% 3588
2025
Q1
$3.92M Buy
339,936
+12,263
+4% +$142K ﹤0.01% 2918
2024
Q4
$2.78M Buy
327,673
+193,632
+144% +$1.64M ﹤0.01% 3276
2024
Q3
$1.55M Sell
134,041
-78,847
-37% -$913K ﹤0.01% 3533
2024
Q2
$2.51M Buy
212,888
+153,057
+256% +$1.8M ﹤0.01% 3058
2024
Q1
$710K Sell
59,831
-27,268
-31% -$323K ﹤0.01% 3810
2023
Q4
$1.07M Sell
87,099
-121,713
-58% -$1.49M ﹤0.01% 3584
2023
Q3
$2.01M Sell
208,812
-84,499
-29% -$814K ﹤0.01% 3096
2023
Q2
$2.64M Buy
293,311
+17,827
+6% +$160K ﹤0.01% 3024
2023
Q1
$2.17M Sell
275,484
-70,221
-20% -$552K ﹤0.01% 3156
2022
Q4
$2.34M Buy
345,705
+7,525
+2% +$50.9K ﹤0.01% 3177
2022
Q3
$4.91M Buy
338,180
+36,905
+12% +$535K ﹤0.01% 2655
2022
Q2
$2.97M Buy
301,275
+134,570
+81% +$1.32M ﹤0.01% 3119
2022
Q1
$2.46M Buy
166,705
+67,274
+68% +$992K ﹤0.01% 3413
2021
Q4
$1.32M Buy
99,431
+30,136
+43% +$399K ﹤0.01% 3818
2021
Q3
$1.21M Buy
69,295
+37,685
+119% +$658K ﹤0.01% 3846
2021
Q2
$757K Sell
31,610
-22,989
-42% -$551K ﹤0.01% 4194
2021
Q1
$1.4M Buy
54,599
+44,029
+417% +$1.13M ﹤0.01% 3672
2020
Q4
$201K Buy
+10,570
New +$201K ﹤0.01% 4269
2020
Q3
Sell
-36,781
Closed -$445K 4497
2020
Q2
$445K Buy
+36,781
New +$445K ﹤0.01% 3653
2020
Q1
Sell
-20,213
Closed -$360K 4485
2019
Q4
$360K Sell
20,213
-26,881
-57% -$479K ﹤0.01% 3796
2019
Q3
$546K Buy
47,094
+26,181
+125% +$304K ﹤0.01% 3559
2019
Q2
$463K Sell
20,913
-16,877
-45% -$374K ﹤0.01% 3559
2019
Q1
$1.08M Buy
+37,790
New +$1.08M ﹤0.01% 3225
2018
Q1
Sell
-15,528
Closed -$151K 4264
2017
Q4
$151K Buy
+15,528
New +$151K ﹤0.01% 3883
2016
Q4
Sell
-6,820
Closed -$44K 4502
2016
Q3
$44K Sell
6,820
-5
-0.1% -$32 ﹤0.01% 4331
2016
Q2
$63K Sell
6,825
-34,994
-84% -$323K ﹤0.01% 4227
2016
Q1
$377K Buy
41,819
+35,332
+545% +$319K ﹤0.01% 3397
2015
Q4
$329K Sell
6,487
-3,490
-35% -$177K ﹤0.01% 3466
2015
Q3
$499K Sell
9,977
-2,095
-17% -$105K ﹤0.01% 3305
2015
Q2
$1.21M Buy
+12,072
New +$1.21M ﹤0.01% 2855